Nexalin Technology (NXL) Receivables - Other (2021 - 2025)
Nexalin Technology's (NXL) quarterly Receivables - Other came in at $27100.0 in Q3 2025, down 69.66% year-on-year from $89330.0 in Q3 2024, and down 38.87% quarter-over-quarter from $44330.0 in Q2 2025.
Nexalin Technology (NXL) Receivables - Other (2021 - 2025) Analysis & Trends
Nexalin Technology's Receivables - Other history runs 5 years deep, the most recent figure standing at $27100.0 for Q3 2025.
- On a quarterly basis, Receivables - Other fell 69.66% year-over-year to $27100.0 in Q3 2025; TTM through Sep 2025 was $27100.0, a 69.66% decrease from a year earlier, with the FY2024 full-year figure at $89330.0, changed 0.0% from the prior year.
- Receivables - Other fell to $27100.0 in Q3 2025 per NXL's latest filing, from $44330.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $336000.0 in Q4 2021 and bottomed at $27100.0 in Q3 2025.
- The 5-year median for Receivables - Other is $89330.0 (2023), against an average of $187386.4.
- Across the five-year window, Receivables - Other changed 0.0% in 2022 and plunged 73.41% in 2023, its largest moves.
- Year by year, Receivables - Other stood at $336000.0 in 2021, then changed by 0.0% to $336000.0 in 2022, then plunged by 73.41% to $89330.0 in 2023, then changed by 0.0% to $89330.0 in 2024, then sank by 69.66% to $27100.0 in 2025.
- Per Business Quant, the three latest NXL Receivables - Other figures stand at $27100.0 (Q3 2025), $44330.0 (Q2 2025), and $89330.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27,100.00 |
| Sep 30, 2025 | 27,100.00 |
| Jun 30, 2025 | 44,330.00 |
| Jun 30, 2025 | 44,330.00 |
| Mar 31, 2025 | 89,330.00 |
| Mar 31, 2025 | 89,330.00 |
| Dec 31, 2024 | 89,330.00 |
| Dec 31, 2024 | 89,330.00 |
| Sep 30, 2024 | 89,330.00 |
| Sep 30, 2024 | 89,330.00 |
| Jun 30, 2024 | 89,330.00 |
| Jun 30, 2024 | 89,330.00 |
| Mar 31, 2024 | 89,330.00 |
| Mar 31, 2024 | 89,330.00 |
| Dec 31, 2023 | 89,330.00 |
| Dec 31, 2023 | 89,330.00 |
| Sep 30, 2023 | 336,000.00 |
| Sep 30, 2023 | 336,000.00 |
| Jun 30, 2023 | 336,000.00 |
| Jun 30, 2023 | 336,000.00 |